喘息治療市場- 世界の産業規模、シェア、動向、機会、予測、薬剤クラス別、投与方法別、流通チャネル別、地域別、競合別、2020-2030F

喘息治療の世界市場規模は、2024年に278億4,000万米ドルとなり、予測期間中のCAGRは4.58%で成長し、2030年には364億7,000万米ドルに達すると予測されています。

市場は、喘息の有病率の上昇、ヘルスケア投資の増加、先端治療薬に焦点を当てた研究開発イニシアチブの拡大により拡大しています。喘息は依然として世界の公衆衛生上の大きな問題であり、特に米国のような国々ではその負担が大きいため、効果的な治療に対する大きな需要が生じています。スマート吸入器やネブライザーといったドラッグデリバリーシステムの技術革新や、生物学的製剤の利用可能性の拡大により、喘息管理は大きく変わりつつあります。生物学的製剤による治療は、重症例に的を絞った介入を行い、転帰を改善し入院を減らします。これらの進歩は、患者中心の精密医療への注目とともに、世界の喘息治療市場の継続的な成長を促進すると予想されます。

市場促進要因

研究開発投資の増加

主な市場課題

先端治療薬の高コスト

主要市場動向

デジタルヘルス技術の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の喘息治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 薬剤クラス別（短時間作用型β刺激薬（SABA）、長時間作用型β刺激薬（LABA）、吸入コルチコステロイド（ICS）、ロイコトリエン修飾薬、免疫調節薬、配合薬、その他）
  • 投与方法別（吸入器、ネブライザー、経口薬）
  • 流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の喘息治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の喘息治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の喘息治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の喘息治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの喘息治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• GlaxoSmithKline, Plc
• AstraZeneca Plc
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim Gmbh
• Merck & Co. Inc.
• Novartis AG
• Sanofi SA
• Roche Holding AG
• Regeneron Pharmaceutical Inc.
• Pfizer Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Asthma Treatment Market was valued at USD 27.84 billion in 2024 and is projected to reach USD 36.47 billion by 2030, growing at a CAGR of 4.58% during the forecast period. The market is expanding due to the rising prevalence of asthma, increased healthcare investment, and growing R&D initiatives focused on advanced therapeutics. Asthma remains a major public health concern globally, particularly in countries like the United States, where its burden has created significant demand for effective treatments. Technological innovations in drug delivery systems-such as smart inhalers and nebulizers-and the growing availability of biologic therapies are transforming asthma management. Biologic treatments offer targeted intervention for severe cases, improving outcomes and reducing hospitalizations. These advancements, along with the focus on patient-centric and precision medicine, are expected to drive continued growth in the global asthma treatment landscape.

Key Market Drivers

Increasing Investment in Research and Development

Substantial investment in R&D is a key driver of innovation in the asthma treatment market. With asthma being a complex, chronic condition, pharmaceutical companies and health organizations are prioritizing the development of new drugs and therapies to meet unmet needs. In the U.S., the National Institutes of Health (NIH) allocates over USD 100 million annually for asthma research, supporting advancements in diagnostics, treatment modalities, and prevention strategies. These investments contribute to breakthroughs in biologics, combination therapies, and personalized medicine approaches that enhance treatment effectiveness and patient outcomes. Furthermore, advancements in drug delivery devices and digital health solutions are improving disease monitoring and self-management.

Key Market Challenges

High Cost of Advanced Therapies

A major barrier in the global asthma treatment market is the high cost of biologic therapies used to treat severe asthma. These treatments, such as monoclonal antibodies, can cost thousands of dollars annually per patient, limiting access in low- and middle-income countries and placing strain on healthcare budgets even in developed regions. Limited insurance coverage and inconsistent reimbursement policies further exacerbate this issue, often resulting in delays or non-adherence to prescribed therapies. While biologics are effective, the associated costs can hinder widespread adoption, and addressing this financial barrier will be crucial for equitable access to advanced asthma treatments.

Key Market Trends

Integration of Digital Health Technologies

The increasing integration of digital technologies is reshaping asthma management. Tools such as mobile apps, wearable devices, and smart inhalers are enabling patients to track symptoms, monitor environmental triggers, and ensure medication adherence in real time. Smart inhalers equipped with sensors send usage data to connected devices, allowing both patients and healthcare providers to assess therapy effectiveness and make timely adjustments. These innovations support personalized asthma management, reduce flare-ups, and decrease hospital visits. As healthcare moves toward remote monitoring and data-driven decision-making, digital health technologies are expected to play a central role in asthma care delivery.

Key Market Players

• GlaxoSmithKline, Plc
• AstraZeneca Plc
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Merck & Co. Inc.
• Novartis AG
• Sanofi SA
• Roche Holding AG
• Regeneron Pharmaceutical Inc.
• Pfizer Inc.

Report Scope:

In this report, the Global Asthma Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Treatment Market, By Drug Class:

• Short-Acting Beta-Agonists (SABA)
• Long-Acting Beta-Agonists (LABA)
• Inhaled Corticosteroids (ICS)
• Leukotriene Modifiers
• Immunomodulators
• Combination Drugs
• Others

Asthma Treatment Market, By Mode of Administration:

• Inhalers
• Nebulizers
• Oral Medications

Asthma Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Asthma Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Treatment Market.

Available Customizations:

Global Asthma Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Asthma Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others)
  • 5.2.2. By Mode of Administration (Inhalers, Nebulizers, Oral Medications)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Asthma Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Mode of Administration
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Asthma Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Mode of Administration
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Mexico Asthma Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Mode of Administration
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Canada Asthma Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Mode of Administration
      • 6.3.3.2.3. By Distribution Channel

7. Europe Asthma Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Mode of Administration
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Asthma Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Mode of Administration
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Germany Asthma Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Mode of Administration
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Asthma Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Mode of Administration
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Asthma Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Mode of Administration
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Asthma Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Mode of Administration
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Asthma Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Mode of Administration
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Asthma Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Mode of Administration
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Asthma Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Mode of Administration
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. South Korea Asthma Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Mode of Administration
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. Japan Asthma Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Mode of Administration
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Asthma Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Mode of Administration
      • 8.3.5.2.3. By Distribution Channel

9. South America Asthma Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Mode of Administration
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Asthma Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Mode of Administration
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Asthma Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Mode of Administration
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Asthma Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Mode of Administration
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Asthma Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Mode of Administration
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Asthma Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Mode of Administration
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Asthma Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Mode of Administration
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Asthma Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Mode of Administration
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. GlaxoSmithKline, Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. AstraZeneca Plc
• 14.3. Teva Pharmaceutical Industries Ltd.
• 14.4. Boehringer Ingelheim Gmbh
• 14.5. Merck & Co. Inc.
• 14.6. Novartis AG
• 14.7. Sanofi SA
• 14.8. Roche Holding AG
• 14.9. Regeneron Pharmaceutical Inc.
• 14.10. Pfizer Inc.

15. Strategic Recommendations

16. About Us & Disclaimer